Literature DB >> 30014137

Assessment of Patterns of Potentially Unsafe Use of Zolpidem.

Thomas J Moore1,2, Donald R Mattison3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30014137      PMCID： PMC6583219          DOI： 10.1001/jamainternmed.2018.3031

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial.

Authors:  Luciana L Louzada; Flávio V Machado; Juliana L Quintas; Guilherme A Ribeiro; Mônica V Silva; Dayde L Mendonça-Silva; Bruno S B Gonçalves; Otávio T Nóbrega; Einstein F Camargos
Journal:  Neuropsychopharmacology       Date:  2021-10-11       Impact factor: 7.853

Review 2.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2016-05-19

3.  Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem.

Authors:  Seonghae Yoon; Seongmee Jeong; Eben Jung; Ki Soon Kim; Inseung Jeon; Yujin Lee; Joo-Youn Cho; Woo-Yong Oh; Jae-Yong Chung
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.